• SELECT SITE CURRENCY
Select a currency for use throughout the site
2009 United States Oncology Drug Delivery Patterns, Preferences, and Opportunities - Volume 1: Oncologist and Infusion Nurse Perspectives
Frost & Sullivan, September 2012, Pages: 97
Drug delivery is an important area of drug development in the pharmaceutical and biotechnology industry. This customer research was completed to understand trends, dynamics, and parameters specific to the delivery of drugs to cancer patients; identify physicians prescribing trends relative to delivery considerations; understand the role of reimbursement in a physician’s choice of drug delivery; and determine product attributes relative to delivery that are considered important by patients and oncologists. This is important for biotechnology products used in this area as companies seek to design new products and evaluate new opportunities for targeted therapies and other cancer treatments.
Potential Trends in Usage
- There is potential for the share of oral medication to increase based on the higher proportion of preference for this method.
- In the next 12-24 months, a significant proportion of oncologists expect oral prescriptions to increase, with IV infusion and IV injection the next leading delivery categories for increased prescription.
- Intravenous injections, intravenous infusions and oral medications are the most prescribed classes of drugs.
- For Cytotoxic therapies, intravenous injection is the most preferred oncology drug delivery mode. Across hormone and targeted therapies, Oral is most preferred.
- Oncologists are most satisfied with intravenous injections and oral drug delivery modes.
- Oral delivery is the leading desired method for new drug development from oncologists.
- After published clinical data, “Practice is Reimbursed” was the second leading reason for drug delivery device selection from oncologists.
- In the next 12-24 months, infusion nurses anticipate a significant amount of change in the oncology drug delivery modes they will administer. The top three modes that are anticipated to increase include: oral, external infusion pump, and implant.
- Infusion nurses most frequently administer intravenous infusion, intravenous injection, and oral modes of oncology drug delivery.
- Infusion nurses are most satisfied with intravenous infusion. They are also satisfied with intravenous injections and external infusion pumps.
- Oral is the most desired method for new drug development from infusion nurses. Infusion nurses desired usage of implant and implantable infusion pump for new products at a significantly higher rate than oncologists.
Potential Trends in Usage for Office Administration of Oncology Drug Treatment:
- Both oncologists and infusion nurses clearly prefer that their patients receive oncology drug treatments in a physician’s office.
- Most oncologists prefer intravenous infusions to be administered in a physician’s office setting.
- Infusion nurses prefer intravenous injection and intravenous infusion to be administered in a physician’s office setting.
- Improves dose accuracy and provides opportunities to track patient progress were two leading reasons for the office setting preference from oncologists and infusion nurses.
Potential Trends in Usage for Home Administration of Oncology Drug Treatment:
- Across all drug delivery methods selected for home administration, improving patient convenience is reported as a primary reason for preferring a home administration method. Patient compliance and improving patient comfort round out the top three reasons for preferring home administration.
- Oncologists view oral drug delivery methods, transdermal patches, and topical gels or creams as leading methods for home administration.
- Amongst infusion nurses, oral drug delivery methods, transdermal patches, and topical gels or creams are viewed as leading methods for home administration.
- Infusion nurses viewed implantable infusion pumps, IM injections, and SC injections as appropriate for home use at a statistically significant higher rate than oncologists.
- Research Objectives and Methods
- Executive Summary and Implications
- Profile of Respondents
- Awareness and Utilization
- Attitudes and Perceptions
- Preference of and Satisfaction with Drug Delivery Methods
- Profile of Patient Compliance
- Oncology Drug Administration Factors and Parameters
- General Criteria and Perceptions that Influence Oncology Drug Delivery Method Selection
- The Frost & Sullivan Story
A sample for this product is available. Please Login/Register to download this sample.